No Picture
News

CymaBay Therapeutics to Report Second Quarter 2019 Financial Results on Wednesday, August 7

NEWARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it… […]